The Hindu Business Line : Medopharm unveils specialty unit

Chennai, June 27 The Chennai-based Rs 150-crore Medopharm Pvt Ltd (MPL) has launched its specialty division Gallant, targeting gynaecology and surgery.

Alongside, the company also unveiled its plans to set up a new plant to make liquid orals and a new block for R&D.

Announcing this at a press conference the Managing Director of the company, Mr Udhan Kumar, said eight new brands on antibiotics, haematinics, anti-fungal and pain management, will be introduced under Gallant division.

The existing division – Radiant, will continue to focus on general medicines, he said.

Currently, the company gets about 85 per cent of its revenues from exports and launching new division would give the company better inroads in the domestic market, Mr Kumar said.

Developing drugs

MPL has two plants, in Guduvancherry near Chennai and in Bangalore. The third plant meant to make liquid orals and the R&D block will come up at its Guduvancherry premises.

These initiatives would help the company shift from replicating to developing drugs, Mr Kumar said.

Besides it would also help it to harness potential in Contract Research and Manufacturing Services (CRAMS), which is growing in India at 23 per cent CAGR for the last five years.

More Stories on : New Projects | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Brazil AIDS group opposes Gilead patent

ICAI to focus on small, medium practice units

KG Info to provide talent search for US, UK clients

B K Birla Group’s Jay Shree Tea acquires Jayantika Tea

Jupiter Bio acquires Merck facility

BVR Subbu taps a new biz opportunity

Medopharm unveils specialty unit

Aurangabad plant gearing up for Bajaj’s 4-wheel LCV

Petrochemicals lie on Germany’s Lapp

Apollo Tyres launches capacity expansion at Africa plants

Output from Panna-Mukta to resume in 15 days

Kesoram Industries decides to borrow more

Kerala looking for tie-up with Kuwait Petroleum Company